What SEC filings does Cerenome, Inc. submit to the SEC?

Cerenome, Inc. (CNSY) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about CNSY?

A Form 4 for CNSY discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the source-reported date, number of shares, price, and updated ownership. These facts do not establish motive or predict future returns.

How do I interpret an 8-K filing from Cerenome, Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for CNSY?

The 10-K is Cerenome, Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all CNSY SEC filings directly on EDGAR?

You can view all historical Cerenome, Inc. filings on the SEC EDGAR company page for CNSY. Each filing card on this page links directly to the original SEC document.

How often does Cerenome, Inc. file with the SEC?

Cerenome, Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling CNSY shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

CNSY SEC Filing News — Cerenome, Inc.

Latest SEC filings for Cerenome, Inc. (CNSY) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-02.

Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various sol…

Sector: Healthcare Industry: Biotechnology Market Cap: $12.4M CIK: 1095981

Total Filings

Bullish Classifications

Bearish Classifications

Insider Transactions

Material Events (8-K)

Periodic Reports

What you're looking at: Each item below is parsed from an actual SEC filing submitted by Cerenome, Inc.. Form 4 = confirmed insider transaction · Form 144 = proposed sale notice · 8-K = material event (earnings, M&A, leadership change, etc.) · 10-Q / 10-K = quarterly / annual report.

CNSY Filing Activity Snapshot 2026-06-05 — 2026-10-02

Insider Transactions (Form 4)

0 buys vs 0 sells

Insider buying and selling activity is balanced in this period.

Insider Transactions 14 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 14 filings in this group are Form 4s for Cerenome, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 14 insider filings shown, the breakdown is 14 option exercise. None of the classified filings involved a discretionary open-market trade, so this period says nothing about what insiders think of the price.

What each transaction type means

Option exercise ×14: The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

van Es-Johansson An (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	921	—	—
`M`	Option exercise derivative · Restricted Stock Units	921	—	—

Filing: Form 4 (Insider Transaction) Insider: van Es-Johansson An (Director) Shares: 921

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Hawkins Richard J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	921	—	—
`M`	Option exercise derivative · Restricted Stock Units	921	—	—

Filing: Form 4 (Insider Transaction) Insider: Hawkins Richard J (Director) Shares: 921

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Clowes Howard (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	921	—	—
`M`	Option exercise derivative · Restricted Stock Units	921	—	—

Filing: Form 4 (Insider Transaction) Insider: Clowes Howard (Director) Shares: 921

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Sims Andrew John Hugh MacIntyre (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	1,533	—	—
`M`	Option exercise	1,165	—	—
`M`	Option exercise	287	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,533	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,165	—	—
`M`	Option exercise derivative · Restricted Stock Units	287	—	—

Filing: Form 4 (Insider Transaction) Insider: Sims Andrew John Hugh MacIntyre (Chief Financial Officer) Shares: 2,985

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

ANDREWS RONALD ASBURY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	921	—	—
`M`	Option exercise derivative · Restricted Stock Units	921	—	—

Filing: Form 4 (Insider Transaction) Insider: ANDREWS RONALD ASBURY (Director) Shares: 921

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

HEDRICK MARC H (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	6,387	—	—
`M`	Option exercise	8,066	—	—
`M`	Option exercise	1,986	—	—
`M`	Option exercise derivative · Restricted Stock Units	6,387	—	—
`M`	Option exercise derivative · Restricted Stock Units	8,066	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,986	—	—

Filing: Form 4 (Insider Transaction) Insider: HEDRICK MARC H (Director, Chief Executive Officer) Shares: 16,439

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-10-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Guse Kyle (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	921	—	—
`M`	Option exercise derivative · Restricted Stock Units	921	—	—

Filing: Form 4 (Insider Transaction) Insider: Guse Kyle (Director) Shares: 921

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

ANDREWS RONALD ASBURY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	922	—	—
`M`	Option exercise derivative · Restricted Stock Units	922	—	—

Filing: Form 4 (Insider Transaction) Insider: ANDREWS RONALD ASBURY (Director) Shares: 922

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Guse Kyle (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	922	—	—
`M`	Option exercise derivative · Restricted Stock Units	922	—	—

Filing: Form 4 (Insider Transaction) Insider: Guse Kyle (Director) Shares: 922

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

van Es-Johansson An (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	922	—	—
`M`	Option exercise derivative · Restricted Stock Units	922	—	—

Filing: Form 4 (Insider Transaction) Insider: van Es-Johansson An (Director) Shares: 922

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	6,387	—	—
`M`	Option exercise	8,066	—	—
`M`	Option exercise	1,986	—	—
`M`	Option exercise derivative · Restricted Stock Units	6,387	—	—
`M`	Option exercise derivative · Restricted Stock Units	8,066	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,986	—	—

Filing: Form 4 (Insider Transaction) Insider: HEDRICK MARC H (Director, Chief Executive Officer) Shares: 16,439

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Clowes Howard (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	922	—	—
`M`	Option exercise derivative · Restricted Stock Units	922	—	—

Filing: Form 4 (Insider Transaction) Insider: Clowes Howard (Director) Shares: 922

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

Hawkins Richard J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	922	—	—
`M`	Option exercise derivative · Restricted Stock Units	922	—	—

Filing: Form 4 (Insider Transaction) Insider: Hawkins Richard J (Director) Shares: 922

View on SEC EDGAR → Open Filing Document →

Form 4 Option exercise Tax / Compensation Filing 2026-07-01

CNSY insider Form 4 filed for equity award, exercise, or tax withholding

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`M`	Option exercise	1,533	—	—
`M`	Option exercise	1,165	—	—
`M`	Option exercise	287	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,533	—	—
`M`	Option exercise derivative · Restricted Stock Units	1,165	—	—
`M`	Option exercise derivative · Restricted Stock Units	287	—	—

Filing: Form 4 (Insider Transaction) Insider: Sims Andrew John Hugh MacIntyre (Chief Financial Officer) Shares: 2,985

View on SEC EDGAR → Open Filing Document →

Material Events 5 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 5 in this period for Cerenome, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-02

CNSY filed 8-K — material company event

CERENOME, INC. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-09-10

CNSY filed 8-K — material company event

CERENOME, INC. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-08-14

CNSY filed 8-K — material company event

CERENOME, INC. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-08-04

CNSY filed 8-K — material company event

CERENOME, INC. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-06-05

CNSY filed 8-K — material company event

CERENOME, INC. filed an 8-K with the SEC reporting a material event. Read the SEC filing for the full details.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Cerenome, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-14

CNSY filed Quarterly Report (10-Q)

CERENOME, INC. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

View on SEC EDGAR → Open Filing Document →

How we classify Cerenome, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CNSY. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CNSY SEC Filings

More Tools for CNSY

CNSY Full Stock Analysis CNSY Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper CNSY analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CNSY stock analysis page.

CNSY Full Analysis

Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.

Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer